Caring Brands, Inc. 8-K

What Happened

• Caring Brands, Inc. announced a private investment in public equity (PIPE) that closed on March 19, 2026, raising $3.6 million from one accredited investor. The company issued Series A Convertible Preferred Stock and 9,473,685 warrants to purchase common shares. The Series A preferred is convertible into common stock at $0.40 per share; the Common Warrants have a $0.40 exercise price and expire five years from issuance.
• The company will use approximately $3.075 million of net proceeds to redeem 6,250,000 common shares held by insiders (1,500,000 from CEO Dr. Glynn Wilson; 1,250,000 from Chairman Brnan John; 3,500,000 from NovoDX, Inc.), reducing outstanding common shares from 14,761,925 to 8,511,925. The Series A Certificate of Designation (filed March 18, 2026) sets a $1,000 stated value per preferred share and an 8% dividend (cash or common at holder’s option).

Key Details

• Aggregate PIPE proceeds: $3,600,000; original-issue discount resulted in $950 purchase price per $1,000 stated-value Series A share.
• Warrants issued: 9,473,685 Common Warrants, exercisable immediately at $0.40, expiring in five years.
• Conversion/exercise limits: issuances cannot exceed 19.99% of outstanding common stock without shareholder approval; purchaser also subject to beneficial ownership caps (generally 4.99% per exercise) and may purchase up to an additional $4.0M of Series A/Warrants under an “Additional Investment Right” (AIR) with pricing protections.
• Corporate rights and resale: Series A holders receive 8% dividends and dividend parity on common dividends (as-if-converted); the company agreed to file registration statements to enable resale of securities issued in the PIPE. No public market is expected for the Series A or warrants.

Why It Matters

• This financing provides immediate cash (net $3.6M) and resolves insider-held shares via redemptions that materially reduce the company’s outstanding common shares — a step that concentrates remaining share ownership and may affect per-share metrics.
• At the same time, the convertible preferred stock and nearly 9.5 million warrants carry the potential for future dilution if converted or exercised (both priced at $0.40), though issuance limits and shareholder approval thresholds apply. The purchaser’s AIR and 12‑month right of first refusal on future financings could shape near-term capital raises.
• Retail investors should note the mix of reduced outstanding common shares (via insider redemptions) and new convertible/warranted securities that may convert into common stock in the future; the company will seek SEC registration for resale of the securities issued in the PIPE.